AHA comments to the Drug Enforcement Administration regarding their efforts to support the safe prescribing of controlled substances via telehealth. Indeed, during the COVID-19 public health emergency
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The AHA provides comments to the Assistant Secretary for Technology Policy (ASTP) on the Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) proposed rule.
The AHA applauds the U.S. Department of Health and Human Services Office of Inspector General (HHS OIG) for your recently announced review of Medicare Advantage Organizations' Use of Prior Authorization for Post-Acute Care.
AHA urges CMS to consider whether adjustments are necessary in its approach to annual market basket updates to ensure that beneficiaries continue to have access to high-quality outpatient care. We also urge CMS to eliminate the productivity cut for CY 2025, as detailed below.
The AHA urges CMS to work with Congress to provide a Physician Fee Schedule payment increase for 2025 and to develop a long-term plan for sustainable physician payment.
The American Hospital Association requests additional funding for the Federal Emergency Management Agency’s Disaster Relief Fund which provides support for authorized
federal disaster activities.
AHA letter regarding the Health Resources and Services Administration’s response to Johnson & Johnson’s (J&J) most recent attempt to undermine the 340B Drug Pricing Program.
The AHA provides comments to CMS on the calendar year 2025 Home Health prospective payment system proposed rule.
AHA comments on MedPAC topics to be considered in the new cycle: the 340B Drug Pricing Program, inpatient rehabilitation facility (IRF) payments, the physician fee schedule (PFS) and telehealth.
AHA's comments on CMS' proposed rule to mitigate the impact of significant, anomalous and highly suspect (SAHS) billing activity within the Medicare Shared Savings Program (MSSP) in calendar year (CY) 2023.